Despite last week’s Arctic blast, a buoyancy filled the air as if spring had arrived after a four-year freeze. U.S.

Pfizer Inc. got a reprieve — at least for now — in its battle with activist investor Starboard Value LP, according to people ...

Following a tough opening salvo from Starboard Value last fall, Pfizer is getting a chance to catch its breath in the ...

These four top dividend stocks offer dependable passive income streams and solid total return, and they are too cheap to ...

Some stocks pay juicy dividends for a while only for the income to later dwindle. Others generate consistent and reliable ...

Pfizer Inc. (NYSE:PFE – Get Free Report) saw unusually large options trading activity on Thursday. Traders acquired 251,131 ...

Large-cap dividend stocks will make sense as rates continue lower next year. These four have yields greater than the 10-year ...

The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light.

Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...

Pharmaceutical stocks can bring an element of safety to your portfolio. All of this equals a rather steady stream of revenue ...

Intercontinental Exchange, Inc. (NYSE: ICE), a leading global provider of technology and data, today announced the launch of the NYSE® IPO Index (NYSEIPO), a new equal-weighted index to track the ...